The National Library of Medicine (NLM) Value Set Authority Center (VSAC) has updated VSAC with the most recent provisional terminology code published by RxNorm in response to the COVID-19 pandemic.

This RxNorm investigational provisional code was developed in response to the COVID-19 pandemic and it is based on the most up to date information available at the time of its creation.

• Code System: RxNorm
• VSAC Code System Version: Provisional_2020-11-17
• Additional Information: Investigational Drugs in RxNorm: Bamlanivimab, a drug allowed under the U.S. Food & Drug Administration Emergency Use Authorization (EUA), was made available in the RxNorm November 12, 2020 weekly releases from the RxNorm Files page. Bamlanivimab will also be included in the RxNorm December 2020 Monthly releases. Get more information about bamlanivimab from the FDA.

Value set authors who create COVID-19 related value sets can Contact NLM to request their COVID-19 value sets be included in a prefiltered VSAC search.

Find information about COVID-19 provisional codes in VSAC.

Last Reviewed: November 17, 2020